Premium
Influenza A H1N1/2009 infection in pediatric solid organ transplant recipients
Author(s) -
Gavaldà J.,
Cabral E.,
Alonso E.,
PerezRomero P.,
Pérez A.,
Quintero J.,
Campins M.,
Vilalta R.,
Alonso A.,
Len O.,
Navarro M.,
Nieto J.,
Jara P.,
Charco R.,
Pahissa A.,
Cordero E.
Publication year - 2012
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12005
Subject(s) - medicine , pneumonia , retrospective cohort study , cohort , kidney transplant , pandemic , organ transplantation , h1n1 pandemic , intensive care medicine , kidney transplantation , pediatrics , covid-19 , transplantation , infectious disease (medical specialty) , disease
Aim and method The aim of this study was to describe the clinical characteristics and outcome of pandemic influenza A H1N1/2009 (pH1N1) infection, in a retrospective cohort of pediatric patients with kidney and/or liver transplant and confirmed pH1N1 infection from June to December 2009, diagnosed in 2 Spanish teaching hospitals. Results Forty‐nine patients were included. Pneumonia was diagnosed in 4 patients (8.2%), and 3 of them required respiratory support. There were no related deaths. Conclusion Antiviral treatment within 48 h was associated with a lower likelihood of pneumonia (0/38, 0%) than treatment started after 48 h (4/11, 36.3%) ( P < 0.01).